Chris Dandrea is a 23 year veteran in the Life Sciences industry with a focus on Drug Development and Commercialization. His current role is Head of Project Management for Sanofi’s Oncology Development Portfolio focuses on the creation of a next generation project management organization to help drive rapid patient access to the innovative drug programs in the growing Sanofi Oncology Portfolio. Previous role was as Global Project Head within Sanofi-Genzyme’s Rare Disease Therapeutic Area covering a spectrum of duties including Phase 3 Development Program Leadership, Marketed Product Life Cycle Management and Portfolio Management to drive future growth. Also at Genzyme, Chris drove the operational Launch of Myozyme®/Lumizyme® for Pompe Disease and Design/Implementation of the Pompe Disease Registry. Prior to Genzyme, Chris was a Management Consultant with PRTM’s (now PWC) Life Sciences Industry Group, a Field Service Engineer with Haemonetics and an Officer in the US Navy. Education includes degrees in Electrical and Biomedical Engineering from Duke University and an MBA from Carnegie Mellon University.